F813-2946 Screening compound: ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate

F813-2946 Screening compound: ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate
F813-2946 Screening compound: ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F813-2946
ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F813-2946

Molecular Formula

C22H25N5O3S2 (C22 H25 N5 O3 S2)

Compound Name

ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate

IUPAC name

ethyl 2-(2-{[2-(4-methylpiperidin-1-yl)-[13]thiazolo[45-d]pyrimidin-7-yl]sulfanyl}acetamido)benzoate

SMILES

CCOC(c(cccc1)c1NC(CSc1c2sc(N3CCC(C)CC3)nc2ncn1)=O)=O

InChI

InChI=1S/C22H25N5O3S2/c1-3-30-21(29)15-6-4-5-7-16(15)25-17(28)12-31-20-18-19(23-13-24-20)26-22(32-18)27-10-8-14(2)9-11-27/h4-7,13-14H,3,8-12H2,1-2H3,(H,25,28)

InChI Key

PXRJNIUSFPBOBA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27193534

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.6

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.722

Distribution Coefficient, logD

4.706

Water Solubility, LogSw

-4.41

Polar Surface Area

77.428

Acid Dissociation Constant (pKa)

8.84

Base Dissociation Constant (pKb)

1.90

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

F813-2946 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Nucleoside Mimetics Library (2197 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Purine Based Nucleoside Mimetics Library (1131 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Cancer
  • Immune system
  • Immune system
Structure:
  • Mimetics
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F813-2946 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F813-2946?
Check Price and Availability of F813-2946, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F813-2946 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F813-2946
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F813-2946
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F813-2946 available by request